Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against? : Clinical Chemistry and Laboratory Medicine

www.degruyter.com uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience.
To understand more about cookies, tags, and tracking, see our Privacy Statement
I accept all cookies for the De Gruyter Online site

Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2014: 0.741
Source Normalized Impact per Paper (SNIP) 2014: 1.011
Impact per Publication (IPP) 2014: 2.310

VolumeIssuePage

Issues

30,00 € / $42.00 / £23.00

Get Access to Full Text

Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?

1 / Giuseppe Lippi2

1Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW, Australia

2U.O. Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy

Corresponding author: Dr. Emmanuel J. Favaloro, Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, SWAHS, Westmead, NSW, 2145, Australia Phone: +61 2 9845 6618, Fax: +61 2 9689 2331

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 49, Issue 5, Pages 755–757, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2011.126, May 2011

Keywords: antithrombotics; apixaban; dabigatran; laboratory testing; monitoring; oral anticoagulants; rivaroxaban

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Emmanuel J. Favaloro, Roslyn Bonar, Jennifer Butler, and Katherine Marsden
Pathology, 2013, Volume 45, Number 4, Page 435
[2]
Sergey V. Brodsky
Kidney Research and Clinical Practice, 2014, Volume 33, Number 4, Page 174
[3]
K. M. Ware, J. C. Vance, N. Muni, L. A. Hebert, A. A. Satoskar, G. Nadasdy, I. Ivanov, T. Nadasdy, B. H. Rovin, and S. V. Brodsky
American Journal of Hypertension, 2015, Volume 28, Number 2, Page 182
[4]
Sophie Yavordios
Revue Francophone des Laboratoires, 2014, Volume 2014, Number 463, Page 37
[5]
M. Ryan, K. Ware, Z. Qamri, A. Satoskar, H. Wu, G. Nadasdy, B. Rovin, L. Hebert, T. Nadasdy, and S. V. Brodsky
Nephrology Dialysis Transplantation, 2014, Volume 29, Number 12, Page 2228
[6]
Christophe A Marquette, Benjamin P Corgier, and Loïc J Blum
Bioanalysis, 2012, Volume 4, Number 8, Page 927
[7]
Job Harenberg, Roland Krämer, Christina Giese, Svetlana Marx, Christel Weiss, and Martin Wehling
Journal of Thrombosis and Thrombolysis, 2011, Volume 32, Number 3, Page 267

Comments (0)

Please log in or register to comment.